Clinical Trials Directory

Trials / Completed

CompletedNCT00775723

Melatonin Production Delay in Preterm Infants

Term-Born Infants at 9 and 12 Months of Age: A Randomized Controlled Trial

Status
Completed
Phase
Study type
Observational
Enrollment
46 (actual)
Sponsor
Tel Aviv University · Academic / Other
Sex
All
Age
9 Months – 12 Months
Healthy volunteers
Not accepted

Summary

Objective: Melatonin production is known to be delayed in preterm-born infants up to 6 months of age. This might be related to exposure of preterm infants to continuous lighting in the NICU during a critical period of pineal gland development. The investigators aimed to test the profile of melatonin production in these infants at 9-12 months of age. Methods: Twenty three term-born and 23 preterm-born infants (gestational age: 29-34 weeks) were studied. The investigators tested nocturnal urinary melatonin excretion, within a repeated measures design, both at 9 and 12 months of age. Nocturnal urine was extracted from diapers and urinary melatonin derivate (6-sulphatoxymelatonin) excretion was analyzed by ELISA assay.

Detailed description

Unlike other organs which show catch up in preterm infants after one year of life, the pineal gland shows persistent delay in melatonin production. This field of research has been neglected lately although there are published recommendations for decrease of bright light in NICUs which prevents melatonin development and production, and also recommendations for melatonin treatment in cases respiration recovery in hospitalized preterm infants.

Conditions

Timeline

Start date
2008-01-01
Primary completion
2008-05-01
Completion
2008-05-01
First posted
2008-10-20
Last updated
2008-11-03

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00775723. Inclusion in this directory is not an endorsement.